Investigations into the interaction between radiotherapy and the host immune system have
uncovered new mechanisms that can potentially be exploited to improve the efficacy of …

Background There is growing evidence to support the hypothesis that radical treatment of
pulmonary oligometastatic disease with stereotactic body radiation therapy (SBRT) can …

Background The intent of this pooled analysis as part of the German society for radiation
oncology (DEGRO) stereotactic body radiotherapy (SBRT) initiative was to analyze the …

Abstract Objectives Stereotactic Ablative Radiotherapy (SABR) has shown high rates of local
control and prolonged survival in early-stage non-small cell lung cancer (NSCLC), though its …

Aim: This study was performed to confirm the superior overall survival (OS) after pulmonary
oligo-recurrence compared to pulmonary sync-oligometastases in a large nationwide study …

The aim of the present study was to evaluate the benefit of chemotherapy, combined with
palliative radiotherapy (PRT) and other local treatments to the metastatic sites, for patients …

Background Our aim is to report treatment efficacy and toxicity of patients treated by robotic
(Cyberknife®) stereotactic body radiotherapy (SBRT) for oligorecurrent lung metastases …

The spectrum hypothesis posits that there are distinct clinical states of metastatic
progression. Early data suggest that aggressive treatment of more biologically indolent …

Stereotactic ablative radiotherapy (SABR) may improve survival in patients with inoperable
pulmonary oligometastases. However, the impact of pulmonary oligometastatic status after …

The present study sought to evaluate the impact of the flattening filter‑free (FFF) technique in
volumetric modulated arc therapy for lung stereotactic body radiotherapy. Its clinical safety …